Journal
NATURE GENETICS
Volume 47, Issue 11, Pages 1242-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.3414
Keywords
-
Categories
Funding
- National Cancer Center, Korea [NCC-1310190, NCC-1410675]
- Harvard Medical School Eleanor and Miles Shore fellowship
- William Randolph Hearst Fund
Ask authors/readers for more resources
A substantial fraction of disease-causing mutations are pathogenic through aberrant splicing. Although genome profiling studies have identified somatic single-nucleotide variants (SNVs) in cancer, the extent to which these variants trigger abnormal splicing has not been systematically examined. Here we analyzed RNA sequencing and exome data from 1,812 patients with cancer and identified similar to 900 somatic exonic SNVs that disrupt splicing. At least 163 SNVs, including 31 synonymous ones, were shown to cause intron retention or exon skipping in an allele-specific manner, with similar to 70% of the SNVs occurring on the last base of exons. Notably, SNVs causing intron retention were enriched in tumor suppressors, and 97% of these SNVs generated a premature termination codon, leading to loss of function through nonsense-mediated decay or truncated protein. We also characterized the genomic features predictive of such splicing defects. Overall, this work demonstrates that intron retention is a common mechanism of tumor-suppressor inactivation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available